Zentalis Pharmaceuticals
ZNTL
#9381
Rank
โ‚ฌ0.12 B
Marketcap
1,24ย โ‚ฌ
Share price
0.00%
Change (1 day)
6.55%
Change (1 year)

EPS for Zentalis Pharmaceuticals (ZNTL)

EPS in 2026 (TTM): -1,58ย โ‚ฌ

According to Zentalis Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -1,67ย โ‚ฌ. In 2021 the company made an earnings per share (EPS) of -3,45ย โ‚ฌ a decrease over its 2020 EPS that were of -2,91ย โ‚ฌ.

EPS history for Zentalis Pharmaceuticals from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-1,58ย โ‚ฌ
2021-3,45ย โ‚ฌ18.48%
2020-2,91ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-0,17ย โ‚ฌ-89.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-0,87ย โ‚ฌ-48.09%๐Ÿ‡บ๐Ÿ‡ธ USA